Lilly provides grants and charitable contributions for healthcare professional education, patient advocacy and consumer education programs in a variety of therapeutic areas through the Lilly Grant Office. Our commitment is to make grant funding available for independent, fair and balanced, scientifically accurate initiatives that receive no influence from our organization in either submission, design, or implementation. Regardless of whether CME or CE credits are offered for healthcare professional participation, Lilly expects that the same high standards apply for all independent educational activities for healthcare professionals.
Additionally, Lilly has entered into partnerships and alliances with other pharmaceutical companies and established grant offices to support continuing medical education for healthcare professionals in specific therapeutic areas.
The application process for all of our grant offices is online. Detailed information about how to register and apply, including documentation requirements, review process, and decision notification, is available in each of the online grant application and management portals.
- Boehringer Ingelheim – Lilly Grant Office
- On January 11, 2011, Boehringer Ingelheim Pharmaceutical Inc. (BIPI) and Lilly announced a global agreement to jointly develop a portfolio of diabetes compounds. We are committed to supporting education that fosters innovative, high quality, independent medical education for healthcare professionals and patients that narrows unmet medical needs, maintains clinical excellence, and measurably improves health outcomes in areas of interest to the BIPI and Lilly Diabetes Alliance.
Dollar Amount: Varies
Deadline: Rolling
Full RFP: https://www.lillygrantoffice.com/grant-application